Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Medicine
  • Medicine News
  • Nirmatrelvir therapy...

Nirmatrelvir therapy proves efficacious in severe Covid-19 during omicron surge: NEJM

Written By : Dr. Kamal Kant Kohli Published On 2022-08-26T11:00:25+05:30  |  Updated On 26 Aug 2022 2:56 PM IST
Nirmatrelvir therapy proves efficacious in severe Covid-19 during omicron surge: NEJM
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Israel: Nirmatrelvir use during the Omicron variant surge was associated with a significant decline in COVID-19 hospitalization and mortality rates in patients 65 and older states a study published in The New England Journal Of Medicine.

In late 2021, the rapidly proliferating B.1.1.529 (omicron) strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global recurrence of coronavirus illness. The oral antiviral nirmatrelvir received an Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA) on December 22, 2021, to address mild to moderate COVID-19 in patients who are at a higher risk of developing serious disease. After receiving a positive COVID-19 diagnosis, the standard nirmatrelvir treatment plan entails five consecutive days of medication. There is a dearth of information on nirmatrelvir's propensity to shield against the B.1.1.529 (omicron) variety of the severe coronavirus illness of 2019 (Covid-19).

The researchers in their study assessed the ability of Nirmatrelvir to shield high-risk patients from COVID-19-related hospitalization and death.

The authors found that the oral protease inhibitor nirmatrelvir has demonstrated significant effectiveness in high-risk, unvaccinated patients infected with the B.1.617.2 (delta) strain.

For this purpose, they gathered information from the electronic medical records of Clalit Health Services (CHS). The drug was administered to CHS patients for the first time on March 10, 2022, which marked the conclusion of the study, which started on January 9, 2022. Participants in the trial have to have a diagnosis of COVID-19 by February 24, 2022. The link between nirmatrelvir treatment and hospitalization and mortality due to Covid-19 was estimated using a Cox proportional-hazards regression model with time-dependent covariates, with adjustments for sociodemographic characteristics, comorbid conditions, and prior SARS-CoV-2 immune status. 3902 (4%) of the 109,254 patients who met the inclusion criteria for treatment received nirmatrelvir.

Key findings of the study:

  • The rate of Covid-19-related hospitalization among patients 65 years of age or older was 14.7 cases per 100,000 person-days among those who received treatment, versus 58.9 cases per 100,000 person-days among those who received no treatment (adjusted hazard ratio, 0.27).
  • The risk ratio for Covid-19-related deaths was 0.21.
  • With regard to patients aged 40 to 64, the rate of hospitalization caused by Covid-19 was 15.2 instances per 100,000 person-days among those who received treatment and 15.8 cases per 100,000 person-days of those who did not (adjusted hazard ratio, 0.74).
  • With a 95% confidence interval of 0.16 to 10.75, the adjusted hazard ratio for Covid-19-related death was 1.32.

"It should be emphasized that the review of safety data reports and adverse event reports were outside the purview of this investigation. More research will be required to evaluate the treatment with nirmatrelvir's short- and long-term safety in practical contexts" added the researchers.

The authors concluded that Nirmatrelvir recipients had significantly reduced rates of severe Covid-19 outcomes than nirmatrelvir non-users during the omicron variant surge among people 65 years of age or older.

REFERENCE

Arbel R, Wolff Sagy Y, Hoshen M, Battat E, Lavie G, Sergienko R, Friger M, Waxman JG, Dagan N, Balicer R, Ben-Shlomo Y, Peretz A, Yaron S, Serby D, Hammerman A, Netzer D. Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge. N Engl J Med. 2022 Aug 24. doi: 10.1056/NEJMoa2204919. Epub ahead of print. PMID: 36001529.

NirmatrelvirCovid‐19OmicronSARS-CoV-2oral protease inhibitorThe New England Journal Of Medicine
Source : The New England Journal Of Medicine
Dr. Kamal Kant Kohli
Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

Show Full Article
Next Story

Editorial

Uncontrolled T2D in India: Valuable Consideration for Dapagliflozin Sitagliptin Combination

Uncontrolled T2D in India: Valuable Consideration for Dapagliflozin Sitagliptin Combination

JAPI Releases Dedicated Supplement Addressing Clinical Needs for Adult Vaccination in India

JAPI Releases Dedicated Supplement Addressing Clinical Needs for Adult Vaccination in India

Cuticapil Stem Hair Serum as Add-On to Minoxidil Shows Superior Hair Growth in Androgenetic Alopecia : Indian Real World Data

Cuticapil Stem Hair Serum as Add-On to Minoxidil Shows Superior Hair Growth in Androgenetic Alopecia...

Prediabetes and MASLD : An Overlapping Spectrum of Metabolic Risk

Prediabetes and MASLD : An Overlapping Spectrum of Metabolic Risk

Bisoprolol in CAD - Key Insights from National Consensus 2025 with Special Focus on Women

Bisoprolol in CAD - Key Insights from National Consensus 2025 with Special Focus on Women

View All

Journal Club Today

Could Smoking and Vaping Be Making Teen Mental Health Worse? Study Sheds Light

Could Smoking and Vaping Be Making Teen Mental Health Worse? Study Sheds Light

View All

Health News Today

Health Bulletin 25/July/ 2025

Health Bulletin 25/July/ 2025

View All
© 2022 All Rights Reserved.
Powered By: Hocalwire
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok